Oncology

The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...

In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...

Researchers determined the impact of melanoma subtypes on cutaneous immune-related adverse events and survival among those who received immune checkpoint inhibitor therapy.

The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.

The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.

The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.

The FDA-approved treatment combines tremelimumab, durvalumab, and platinum-based chemotherapy, and follows a randomized trial.

Researchers find that people diagnosed with a rare subtype of breast cancer are at a high risk of cancer spreading to their brains.